A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) A61K 38/17 (2006.01) A61P 35/00 (2006.01) C07K 16/28 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2422095
The present invention relates to methods of modulating angiogenesis and inhibiting tumor progression by using TWEAK receptor (Fn14) agonists. In particular, methods for inhibiting angiogenesis are disclosed.
La présente invention porte sur des procédés de modulation de l'angiogenèse et d'inhibition de la progression tumorale qui utilisent des agonistes du récepteur TWEAK (Fn14). L'invention porte notamment sur des procédés d'inhibition de l'angiogenèse.
Browning Jeffrey
Burkly Linda
Jakubowski Aniela
Zheng Timothy
Biogen Inc.
Biogen Idec Ma Inc.
Smart & Biggar
LandOfFree
Tweak receptor agonists as anti-angiogenic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tweak receptor agonists as anti-angiogenic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tweak receptor agonists as anti-angiogenic agents will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1963100